Third degree atriventricular block with α interferon: A case report;Apparition d'un bloc auriculo-ventriculaire du troisieme degre sous interferon α: A propos d'un cas

Archives des Maladies du Coeur et des Vaisseaux

Volumn 92, Issue 1, 1999, Pages 53-56

  Parrens, E ^a   Chevalier, J M ^b   Rougier, M ^a   Douard, H ^a   Labbe L ^a   Quiniou, G ^b   Broustet, A ^c   Broustet, J P ^a  

^a Service de Cardiologie   (France)

^b Service de Cardiologie   (France)

^c Centre Magendie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOTOXICITY; CASE REPORT; DRUG EFFECT; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; IATROGENIC DISEASE; MALE; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY;

CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART BLOCK; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PYRROLIDINES; VASODILATOR AGENTS;

EID: 0032943939     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferon in cancer patients : a review. J Clin Oncol 1986 ; 4 (2) : 234-43.
2. Diskson D. Death halts interferon in France. Science 1982 ; 218 : 772.
3. Sonnenblick M, Rosenmann D, Rosin A. Reversible cardiomyopathy induced by interferon. Br Med J 1990 ; 300 : 1174-5.
4. Ferrari E, Taillan B, Gibelin P, Fuzibet JG, Dujordin P, Morand P. Les complications cardiovasculaires de l'interféron. À propos d'un cas d'hypertension artérielle. Ann Cardiol Angeiol 1992 ; 41 : 437-41.
5. Teragawa H, Hondo T, Amano H et al. Cardiogenic shock following recombinant alpha-2b interferon therapy for chronic hepatitis C : a case report. Jpn Heart J 1906 ; 37 : 137-42.
6. Martino S, Ratanatharathorn V, Karanes C et al. Reversible arrhythmias observed in patients treated with recombinant alpha 2 interferon. J Cancer Res Clin Oncol 1987 ; 113 : 376-8.
7. Lee KH, Gutterman JU, Ali MK, Talpaz M. Cardiac arrhythmia in a CML patient treated with interferon. Texas Med 1989 ; 4 : 36-8.
8. Teragawa H, Hondo T, Takahashi K et al. Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 1996 ; 35 : 19-23.
9. Daubert JC, Blanc JJ, Godin JF et al. Indications de la stimulation cardiaque définitive en 1986. Arch Mal Cœur 1986 ; 79 : 1221-30.
10. Lampidis TJ, Brouty-Boye D. Interferon inhibits cardiac cell function in vitro. Proc Soc Exp Biol Med 1981 ; 166 : 181-5.